Carlyle, the private equity giant, is among the suitors vying to buy Reckitt Benckiser’s infant nutrition arm in China as the world’s most populous nation grapples with a declining birth-rate.
Sky News has learnt that the buyout firm is among a number of parties who were preparing to table offers for the Greater China unit of Mead Johnson ahead of a deadline on Thursday.
Market sources said that Yili, one of the biggest existing players in the country’s infant nutrition market, was also expected to bid, alongside several other financial and strategic bidders.
Source: Sky News
By Mark Kleinman
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.